Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime®) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime®) alone for the treatment of cutaneous leishmaniasis
- 6 April 2004
- journal article
- clinical trial
- Published by Wiley in International Journal of Dermatology
- Vol. 43 (4) , 281-283
Abstract
Background Cutaneous leishmaniasis (CL) is a parasitic disease caused by Leishmania species. There is a need for more effective and less time‐consuming therapeutic methods for this condition.Aim To evaluate the efficacy of combined cryotherapy and intralesional meglumine antimoniate (MA) (Glucantime®, Specia, Paris, France) for the treatment of CL.Methods Patients were divided into three groups: Group 1, 100 patients with 149 lesions were treated with cryotherapy plus intralesional MA; Group 2, 200 patients with 230 lesions were treated with cryotherapy; Group 3, 100 patients with 160 lesions were treated with intralesional MA. These groups were followed for 6 months after the end of treatment.Results The results showed complete cure in 90.9% of cases in Group 1, 57.15% of cases in Group 2, and 55.63% of cases in Group 3. The difference between Group 1 and the other groups was statistically significant (P < 0.05).Conclusions Combined cryotherapy and intralesional MA is more effective than either cryotherapy or intralesional MA alone for the treatment of CL.Keywords
This publication has 11 references indexed in Scilit:
- A comparative controlled trial of intralesionally-administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasisClinical and Experimental Dermatology, 1997
- A comparative controlled trial of intralesionally-administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasisClinical and Experimental Dermatology, 1997
- Cutaneous leishmaniasisClinics in Dermatology, 1996
- CUTANEOUS LEISHMANIASIS: SCHEDULES FOR INTRALESIONAL TREATMENT WITH SODIUM STIBOGLUCONATEInternational Journal of Dermatology, 1996
- INTRALESIONAL TREATMENT OF CUTANEOUS LEISHMANIASIS WITH SODIUM STIBOGLUCONATE ANTIMONYInternational Journal of Dermatology, 1993
- Cutaneous LeishmaniasisInternational Journal of Dermatology, 1990
- Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimonyBritish Journal of Dermatology, 1988
- Treatment of cutaneous leishmaniasis with an intralesional antimonial drug (Pentostam)Journal of the American Academy of Dermatology, 1986
- Cryotherapy in Acute Cutaneous LeishmaniasisInternational Journal of Dermatology, 1986
- Cryosurgery in cutaneous leishmaniasisBritish Journal of Dermatology, 1982